"10.1371_journal.pone.0089232","plos one","2014-02-19T00:00:00Z","Rossana Domenis; Natascha Bergamin; Giuseppe Gianfranceschi; Carlo Vascotto; Milena Romanello; Silvia Rigo; Giovanna Vagnarelli; Massimo Faggiani; Piercamillo Parodi; Mark R Kelley; Carlo Alberto Beltrami; Daniela Cesselli; Gianluca Tell; Antonio Paolo Beltrami","Department of Medical and Biological Sciences, University of Udine, Udine, Italy; Department of Experimental and Clinical Medical Sciences, University of Udine, Udine, Italy; Department of Pediatrics (Section of Hematology/Oncology), Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, United States of America","Conceived and designed the experiments: DC GT APB. Performed the experiments: RD NB GG CV MR GV MF SR. Analyzed the data: RD NB CV MR DC GT APB. Contributed reagents/materials/analysis tools: MRK CAB PP. Wrote the paper: DC APB GT CAB.","The authors have read the journals policy and declare that they have no conflict of interest, with the exception of Dr. Mark R. Kelley, who is the Chief Scientific Founder and consultant for ApeX Therapeutics, a company that has licensed IP from his work. Dr. Beltrami is a PLoS ONE Editorial Board member, but this does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","02","Rossana Domenis","RD",14,TRUE,3,8,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
